Evidence map›Paper›PMID 35440338›Full record

ArticleInfectious disorders drug targets2022

COVID-19 Vaccination, Peltzman Effect and Possible Increase in Highrisk Behaviors: A Growing Concern Related to Risk Compensation and Reduced Compliance to Public Health Protective Measures after Vaccines Rollout.

Shahab Falahi, Jasem Mohamadi, Hojjat Sayyadi, Iraj Pakzad, Ayoub Rashidi, Razi Naserifar, Jahangir Abdi, Azra Kenarkoohi

Abstract read
PubMed Publisher
In one paragraph

Article in Infectious disorders drug targets, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shahab FalahiZoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Jasem MohamadiDepartment of Pediatrics, School of Medicine, Emam Khomeini Hospital, Ilam University of Medical Sciences, Ilam, Iran.ORCID 0000-0001-8832-9617
Hojjat SayyadiDepartment of Biostatistics, Faculty of Health, Ilam University of Medical Sciences, Ilam, Iran.ORCID 0000-0002-8348-3604
Iraj PakzadDepartment of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Ayoub RashidiPublic Health Staff, Infectious Diseases Control Unit, Ilam University of Medical Sciences, Ilam, Iran.ORCID 0000-0001-7645-869X
Razi NaserifarZoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.ORCID 0000-0001-6946-9083
Jahangir AbdiZoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.ORCID 0000-0002-3615-5106
Azra KenarkoohiZoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.ORCID 0000-0002-9928-8627
Medical University of Ilam · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The world is still faced with widespread dissemination and many unanswered questions related to Coronavirus disease (COVID-19). Several candidate vaccines have been introduced against COVID-19, mostly requiring the injection of two doses and some with nearly 90-95% efficacy. All strategies against the spread of infection have focused on breaking the chain of virus transmission through protective public health measures and mass vaccination. The current situation emphasizes the global need for carefully designed policies to maximize vaccine access and uptake. The risk compensation theory (Peltzman Effect) states that the decrease in perceived risk through access to preventive measures may lead to increasing frequency of risky behaviors. The current pandemic has exposed people to the sense of risk compensation and behavior change in response to the perceived risk. Risk compensation phenomenon may significantly reverse the benefits of COVID-19 vaccination, especially if the vaccine is not sufficiently effective in real life or among high-risk populations. Recognition and awareness of Peltzman risk compensation are of high importance in counteracting and neutralizing the false complacency of the community, which also lends more weight to public health efforts. The public health messages and practices should be clearly expressed, straightforward, reliable and applicable. It is important to encourage mass vaccination of the population, and other NPIs must be re-established and implemented to ensure education to live with COVID-19 in parallel with daily activities and job tasks.

Indexed as

COVID-19highrisk behaviorsnon-pharmaceutical interventionspandemicPeltzman effectpublic health measuresrisk compensationrisk homeostasisrisk managementvaccinationvaccines rollout

Identifiers

PMID35440338
OpenAlexW4224272611

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.